Escherichia coli for secretory expression of beta-galactosidase and application thereof
By heterologously expressing β-galactosidase of Lactobacillus delbrueckii subsp. bulgaricus in Escherichia coli, the problem of obtaining intracellular enzymes from Lactobacillus was solved, achieving efficient extracellular expression and lactose conversion, and improving the efficiency of galactooligosaccharide production and the ease of purification.
Patent Information
- Application Number
- CN202411340374.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-25
- Publication Date
- 2024-11-22
AI Technical Summary
In existing technologies, β-galactosidase derived from Lactobacillus is an intracellular enzyme, which is difficult to obtain and affects the yield and activity of the enzyme. Furthermore, the preparation of galactooligosaccharides from fermented lactose is subject to separation and purification limitations, which affects industrial applications.
The pET28a vector was used to heterologously express β-galactosidase of Lactobacillus delbrueckii subsp. bulgaricus in Escherichia coli. Extracellular expression was induced by adding 8-30 mM lactose at 25-30℃ for 16-28 hours. Escherichia coli Rosetta-gami (DE3) was used as the starting strain.
It achieved efficient secretory expression of β-galactosidase, with an enzyme activity of 1.3×10⁵ U/mL, a lactose conversion rate of 98%, and an oligogalactosidase production rate of 71%. It also simplified the purification process and was superior to commercially available enzymes.
Smart Images

Figure CN118995556A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of genetic engineering, in particular to an Escherichia coli that secretes and expresses beta-galactosidase and an application thereof. Background Art
[0002] β-galactosidase (EC 3.2.1.23) belongs to the class of hydrolases and also has the properties of transferases. On the one hand, β-galactosidase can catalyze the hydrolysis of lactose to produce glucose and galactose, and on the other hand, it can also catalyze the transglycosylation reaction of galactosyl groups to lactose and other receptors. For example, the commonly used prebiotics, galactooligosaccharides (GOS), use lactose as a substrate and utilize the transglycosylation reaction of β-galactosidase to produce a complex oligosaccharide mixture with different degrees of polymerization and glycosidic bonds. As a classic prebiotic, GOS can directly reach the large intestine from the upper intestine of the human body without being hydrolyzed or digested, selectively promote the growth of beneficial bacteria such as bifidobacteria and lactobacilli in the intestine, and inhibit the growth of intestinal pathogenic bacteria, thereby improving the composition of intestinal flora and having a positive effect on immune response and metabolic syndrome markers.
[0003] β-galactosidase from Lactobacillus is of great value in the production of GOS and is a good source of β-galactosidase. It has attracted much attention since its discovery. First of all, Lactobacillus is a "generally recognized as safe" microorganism with a long history of application in the field of food fermentation. In addition, studies have found that GOS synthesized using β-galactosidase from Lactobacillus will most likely selectively promote the growth of these two types of bacteria in the intestine, improve the metabolic activity of the strain in the intestine, and thus increase the probiotic effect. Moreover, most of the β-galactosidase from Lactobacillus belongs to the glycosyl hydrolase 2 family (GH2), and most of the β-galactosidase with transglycosylation activity comes from this family, and a very small part comes from the glycosyl hydrolase 42 family (GH42).
[0004] However, the current technology of using lactobacillus to ferment β-galactosidase for the production of oligogalactose still has many shortcomings. β-galactosidase is an intracellular enzyme in lactobacillus, and lactobacillus, as a Gram-positive bacteria, is limited by the difficulty of breaking the cell wall, which affects the yield and activity of the enzyme. In addition, there are limitations on separation and purification when using wild-type lactobacillus to ferment lactose to prepare oligogalactose. These problems directly affect the purity and purification cost of the product, and seriously limit the application of β-galactosidase in industry. Summary of the invention
[0005] In order to solve the above technical problems, the present invention provides an Escherichia coli that secretes and expresses β-galactosidase and its application, wherein the pET28a vector is used in the starting strain to heterologously express β-galactosidase from Lactobacillus delbrueckii subspecies bulgaricus, and the nucleotide sequence is shown in SEQ ID NO. 3. Lactose at a concentration of 8-30 mM is added to the expression system for induction for 16-28 hours, so that the recombinant Escherichia coli expresses β-galactosidase extracellularly, which can be used to synthesize oligosaccharides using lactose as a substrate.
[0006] The first object of the present invention is to provide an Escherichia coli that efficiently secretes and expresses β-galactosidase, wherein the Escherichia coli heterologously expresses β-galactosidase derived from Lactobacillus delbrueckii subspecies bulgaricus using a pET28a vector in a starting strain.
[0007] Furthermore, the nucleotide sequence of the β-galactosidase is shown in SEQ ID NO.3.
[0008] Furthermore, the starting strain is Escherichia coli Rosetta-gami (DE3).
[0009] Furthermore, the β-galactosidase gene was cloned between the Nde I and Xho I restriction sites of the pET28a vector.
[0010] The second object of the present invention is to provide a microbial agent comprising the above-mentioned Escherichia coli.
[0011] The third object of the present invention is to provide the use of the above-mentioned Escherichia coli or the above-mentioned microbial agent in the preparation of β-galactosidase.
[0012] Furthermore, lactose is added to the expression system to induce the Escherichia coli to express β-galactosidase extracellularly.
[0013] Furthermore, the induction is carried out at a temperature of 25-30°C.
[0014] Preferably, the induction is performed at a temperature of 25°C.
[0015] Furthermore, the concentration of lactose is 8-30 mM.
[0016] Preferably, the concentration of lactose is 12 mM.
[0017] Furthermore, the induction lasts for 16-28 hours.
[0018] The fourth object of the present invention is to provide the use of the above-mentioned Escherichia coli or the microbial agent described in claim 3 in the synthesis of galacto-oligosaccharides.
[0019] Further, the following steps are included:
[0020] Step S1, adding lactose to the expression system to induce the Escherichia coli to express β-galactosidase extracellularly to obtain an enzyme solution;
[0021] Step S2: The conversion system uses lactose as a substrate, the concentration of lactose in the system is 3-60%, and enzyme solution is added to carry out the conversion reaction.
[0022] Preferably, in step S2, the concentration of lactose in the conversion system is 60%.
[0023] Furthermore, in step S2, the hydrolysis activity of the enzyme solution is 500-1000 U / mL.
[0024] Furthermore, in step S2, the duration of the conversion reaction is 3-24 hours.
[0025] Furthermore, in step S2, after the conversion reaction is completed, the system is heated at 100° C. for 10 minutes to inactivate the enzyme in the system, and the denatured enzyme is removed by centrifugation.
[0026] Beneficial effects of the present invention:
[0027] The hydrolysis activity of the β-galactosidase prepared by the present invention can reach up to 1.3×10 5 U / mL, avoiding the cell disruption step required for intracellular expression in E. coli and facilitating the purification of the target protein. The enzyme can be used to synthesize galacto-oligosaccharides using lactose as a substrate, with a lactose conversion rate of 98% and a galacto-oligosaccharide generation rate of 71%. It has a good degree of polymerization and is much better than commercial enzymes in terms of lactose conversion, and has broad application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] In order to make the content of the present invention more clearly understood, the present invention is further described in detail below according to specific embodiments of the present invention in conjunction with the accompanying drawings, wherein
[0029] Figure 1 The construction of the recombinant expression vector pET28a(+)-LDBUBgal in Example 2 of the present invention, wherein A is a schematic diagram of the recombinant expression vector, B is a colony PCR verification result diagram of Escherichia coli JM109 transformed with pET28a(+)-LDBUBgal, and lanes 1-6 are preliminary verified correct transformants;
[0030] Figure 2The results of the expression of extracellular and intracellular proteins and the detection of hydrolysis activity of Escherichia coli Rosetta-pET28a(+)-LDBUBgal in Example 3 of the present invention are shown; wherein A is the SDS-PAGE detection of the expression of extracellular and intracellular proteins after induction with 100 μM lactose and IPTG, respectively; Lane M is a protein marker; Lanes 1, 3 and 5 are the extracellular proteins after induction with lactose at 16°C, 25°C and 30°C, respectively; Lanes 2, 4 and 6 are the intracellular proteins after induction with lactose at 16°C, 25°C and 30°C, respectively; Lanes 7 and 8 are the extracellular and intracellular proteins after induction with 100 μM IPTG, respectively; B is the extracellular and intracellular hydrolysis activity of LDBUBgal under different induction conditions;
[0031] Figure 3 The extracellular hydrolysis activity and extracellular protein expression of LDBUBgal induced by different concentrations of lactose at different times in Example 3 of the present invention are detected, wherein A is the extracellular hydrolysis activity detection; B is the SDS-PAGE detection of extracellular protein expression after 28 hours of induction, the M lane is the protein marker, the lane 1 is the Rosetta-pET28a (+) extracellular protein, the lanes 2-11 are the extracellular proteins induced by 0mM, 0.5mM, 1mM, 2mM, 4mM, 8mM, 12mM, 16mM, 20mM and 30mM lactose, respectively, and the lane 12 is the extracellular protein after 100μM IPTG induction;
[0032] Figure 4 The analysis of the lactose product catalyzed by LDBUBgal in Example 4 of the present invention; wherein A is the HPLC detection of the product converted by LDBUBgal into lactose; wherein lac is lactose, gal is galactose, glc is glucose, allo is allolactose, trisa is GOS trisaccharide, tetra is GOS tetrasaccharide, and penta is GOS pentose; B is the MALDI-TOF-MS detection of the lactose product converted by LDBUBgal;
[0033] Figure 5 The construction and verification of the recombinant expression vectors Rosetta-pET32a(+)-LDBUBgal, pRSFDuet-1-LDBUBgal and Rosetta-pETDuet-1-LDBUBgal in Comparative Example 1 of the present invention; wherein A is a schematic diagram of the three recombinant expression vectors; B is the PCR verification of the three recombinant expression vectors transformed into Escherichia coli JM109 colonies, and lanes 1-6 are preliminary verification of the correct transformants;
[0034] Figure 6The present invention is a comparative example 1 of the present invention, wherein A is the extracellular and intracellular protein expression of the recombinant Escherichia coli Rosetta-pET32a(+)-LDBUBgal, Rosetta-pRSFDuet-1-LDBUBgal and Rosetta-pETDuet-1-LDBUBgal and the hydrolysis activity detection; wherein A is the extracellular and intracellular protein expression of the three recombinant Escherichia coli, the M lane is the protein marker, and the 1-3 lanes are the extracellular proteins of Escherichia coli Rosetta-pET32a(+)-LDBUBgal, Rosetta-pETDuet-1-LDBUBgal and Rosetta-pRSFDuet-1-LDBUBgal respectively; 4-6 are the intracellular proteins of the three recombinant Escherichia coli Rosetta-pET32a(+)-LDBUBgal, pETDuet-1-LDBUBgal and Rosetta-pRSFDuet-1-LDBUBgal; and B is the extracellular and intracellular hydrolysis activity detection of the three recombinant Escherichia coli. DETAILED DESCRIPTION
[0035] The present invention is further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.
[0036] β-galactosidase activity detection: Take 125μL of the supernatant of the bacterial cell disruption liquid and add it to a 1.5mL EP tube, balance it at 37℃±0.5℃ for 15min, then quickly add 625μL oNPG substrate solution (need to be balanced at 37℃±0.5℃ before use), cover and mix by inversion. Under constant temperature conditions of 37℃±0.5℃, react accurately for 10min, then quickly add 250μL 1M sodium carbonate solution, shake to mix, and let stand. The order of adding oNPG substrate and sodium carbonate solution is reversed, and the remaining steps are the same as the sample treatment method, as a blank control group. Within 30min, measure the absorbance of the sample test solution and the blank solution at 420nm. One unit of enzyme activity (U) is defined as the release of 1μM oNP by oNPG per milliliter of fermentation liquid per minute.
[0037] Example 1: Screening of β-galactosidase from different lactobacilli
[0038] (1) Cultivation of different lactobacilli and acquisition of crude enzyme solution: Highly active β-galactosidase was screened from 13 lactobacilli stored in the laboratory. The strains stored in a -80°C refrigerator were taken out and thawed, inoculated into 20 mL MRS liquid culture medium at a 2% inoculation amount, and placed in an anaerobic incubator (37°C, 80% CO2, 10% H2, 10% N2) for 36-48 hours to obtain a well-grown bacterial solution. 3-5 μL of the bacterial solution was transferred to MRS solid culture medium and cultured anaerobically at 37°C for 36-48 hours. A single colony was picked and inoculated into 20 mL MRS liquid culture medium, and continued to culture anaerobically at 37°C for 36-48 hours to cultivate lactic acid bacteria with good vitality. The cell wall of lactic acid bacteria was broken by ultrasonic disruption, and the conditions were: 400W, 30min, ultrasound on 3s off 2s. After ultrasonic disruption, centrifuge at 12000 rpm for 30 min and retain the supernatant of the bacterial disruption solution.
[0039] (2) Detection of β-galactosidase activity in crude enzyme solutions of different lactobacilli: The β-galactosidase activity of the crude enzyme solution of the supernatant of the above-obtained crushed liquid was detected. As shown in Table 1, the β-galactosidase activity of Lactobacillus delbrueckii subsp. bulgaricus was 1090.05 U / mL, which was significantly higher than the β-galactosidase activity of other lactobacilli.
[0040] Table 1 Enzyme activities of 13 lactobacilli and the β-galactosidase they produced
[0041]
[0042]
[0043] Example 2: Construction of recombinant expression vector and recombinant strain
[0044] (1) Obtaining the pET28a(+)-LDBUBgal gene: Homologous primers were designed based on the β-galactosidase gene sequence from Lactobacillus delbrueckii subspecies bulgaricus in the database. The primers contained homologous arms near the Nde I and Xho I restriction sites on the multiple cloning site of the pET28a(+) plasmid to be used in the next step. The primer sequences are shown in SEQ ID NO.1 and SEQ ID NO.2. The extracted genome of L.bulgaricus was used as a template to obtain the LDBUBgal target gene (SEQ ID NO.3) by PCR, and the PCR product was recovered by agarose gel;
[0045] Nde I-Rosetta-pET28a(+)-LDBUBgal-F: 5'-gtgccgcgcggcagccatatgATGAGCAATAAGTTAGTAAAAGAAAAAAGA-3' (SEQ ID NO. 1);
[0046] Xho I-Rosetta-pET28a(+)-LDBUBgal-R: 5'-gtggtggtggtggtgctcgagTTATTTTAGTAAAAGGGGCTGAATCA-3' (SEQ ID NO. 2).
[0047] (2) Construction of pET28a(+)-LDBUBgal recombinant expression vector: Schematic diagram of pET28a(+)-LDBUBgal recombinant expression vector is shown in Figure 1 As shown in A. The recombinant pET28a(+) was double-digested with Nde I and Xho I, and the digested product was recovered by agarose gel. The digested product and the LDBUBgal target gene obtained by PCR amplification were connected by homologous recombinase, and reacted at 37°C for 30 minutes to promote the recombination of the target gene and the pET28a(+) vector. The homologous recombinant product was transformed into Escherichia coli JM109, and after overnight culture at 37°C, the positive transformants were picked out and the colony PCR verification was performed using the above primers, as shown in FIG. Figure 1 The transformants shown in lanes 1-6 in B. The transformants that showed positive results were transferred to 5 mL LB medium, cultured in a shaking incubator at 37°C for 12 h, and then sent for sequencing analysis, and the plasmids therein were extracted respectively.
[0048] (3) Construction of LDBUBgal recombinant strain: The plasmid in the positive transformant sequenced correctly in step (2) was transformed into Escherichia coli to obtain recombinant Escherichia coli Rosetta-pET28a(+)-LDBUBgal.
[0049] Example 3: Expression of LDBUBgal and detection of hydrolysis activity
[0050] (1) Expression of LDBUBgal by recombinant E. coli: The correctly verified transformants were transferred to 5 mL LB seed medium, cultured in a shaking incubator at 37°C for 12 h, and then transferred to 50 mL TB medium and cultured until OD 600When the pH value reaches between 0.6 and 0.8, 100 μM lactose is used to induce protein expression at 16°C, 25°C and 30°C, and 100 μM IPTG is used as a control. After the fermentation, the supernatant and the cells are collected by centrifugation at 8000 rpm for 10 min. The cells are resuspended in phosphate buffer (pH = 7.4) and then ultrasonically disrupted (300 W, 15 min, ultrasonic on time 3.0 s, ultrasonic off time 3.0 s). After the supernatant is collected by centrifugation at 10000 rpm for 30 min for SDS-PAGE to detect the expression of the protein. Figure 2 As shown in A, LDBUBgal can be efficiently expressed at three temperatures, but the protein is concentrated in the cell. After induction at 25°C and 30°C, there is a small amount of secretory expression outside the cell, and the amount of secretory expression induced at 25°C is higher.
[0051] (2) LDBUBgal hydrolysis activity detection: The hydrolysis activity of LDBUBgal induced in and outside the cell was detected, such as Figure 2 As shown in B, when a lower lactose concentration of 100 μM was used for induction, since LDBUBgal was mainly expressed intracellularly, its intracellular hydrolysis activity could reach a maximum of 92163.76 U / mL and its extracellular hydrolysis activity could reach a maximum of 2099.71 U / mL after induction at 25°C.
[0052] (3) Optimization of LDBUBgal lactose induction conditions: 0 mM, 0.5 mM, 1 mM, 2 mM, 4 mM, 8 mM, 12 mM, 16 mM, 20 mM and 30 mM lactose were used for induction at 25°C for 0-28 hours. The extracellular expression level after induction was as follows: Figure 3 As shown in B, the extracellular expression of LDBUBgal increased significantly with the increase of lactose induction concentration. Induction with 8mM lactose resulted in a significantly high level of extracellular expression, and increasing the lactose induction concentration to 12mM significantly enhanced the extracellular expression of LDBUBgal. On this basis, further increasing the lactose concentration would not result in a significant difference in the extracellular expression of the protein.
[0053] LDBUBgal extracellular hydrolysis activity assay Figure 3 As shown in A, the extracellular hydrolytic activity gradually increased with the extension of induction time. It is worth noting that when the induction was less than 10 hours, the extracellular hydrolytic activity did not continue to increase with the increase of lactose concentration. However, after 18 hours of induction, the hydrolytic activity gradually increased with the increase of lactose concentration. When induced with 16mM lactose, the hydrolytic activity showed a steady upward trend with the extension of induction time and reached a peak after 24 hours of induction. After 28 hours of induction with 20mM lactose, the extracellular hydrolytic activity of LDBUBgal reached its peak, reaching 1.3×10 5The level of U / mL was increased 27-fold compared to induction with 100 μM IPTG. Nevertheless, induction with a higher lactose concentration of 30 mM for 28 h did not result in a significant improvement in extracellular hydrolytic activity, although it showed a trend superior to that observed with 20 mM lactose induction during the first 24 h.
[0054] Example 4: Detection of GOS yield and degree of polymerization by LDBUBgal-catalyzed lactose synthesis
[0055] (1) Setting up the transformation system: Use 10 mL of the transformation system, the initial concentration of lactose used is 60%, heat to 90°C to dissolve it, and adjust the pH of the system to about 7.4 after cooling to room temperature; add LDBUBgal enzyme solution with a hydrolysis activity of 500-1000U / mL, and do not add enzyme solution to the control group, but use the same volume of buffer solution instead. The experimental group containing LDBUBgal and the control group without LDBUBgal are placed at 37°C and 100-220rpm for reaction for more than 3-24 hours;
[0056] (2) Product post-treatment and detection analysis: The above reaction system was heated at 100°C for 10 minutes to inactivate the enzyme in the system, and centrifuged at 12000 rpm for 10 minutes to remove the denatured enzyme to obtain the converted sugar solution. After the solution was appropriately diluted, the product was analyzed and detected by HPLC using an Agilent 1260 HPLC system, with the differential detector and column temperature set to 38°C, the chromatographic column being XbridgeTM Amide (3.5μm, 4.6×250nm), and the mobile phase consisting of acetonitrile and water in a ratio of 7:3, and the flow rate was set to 1mL / min. Figure 4 As shown in A, in addition to unreacted lactose, the system also includes galactose and glucose obtained by hydrolyzing lactose with LDBUBgal, as well as GOS with different polymerization degrees. According to calculation and analysis, the conversion rate of lactose is 98%, and the generation rate of GOS is 71%.
[0057] (3) The catalytic GOS product was appropriately diluted and detected using MALDI-TOF-MS. The supersaturated solution of DHB was mixed with the diluted solution at a ratio of 1:1 to a concentration of 1 mg / mL. 2 μL of the mixture was extracted and + Detection is performed in mode. Figure 4 As shown in B, the MALDI-TOF-MS results show that the system contains trisaccharides, tetrasaccharides, pentoses and hexoses in addition to monosaccharides and disaccharides, that is, the maximum polymerization degree of GOS can reach 6. Compared with the polymerization degree of GOS catalyzed by β-galactosidase obtained by recombinant expression from other sources, the polymerization degree of GOS catalyzed by LDBUBgal of the present invention is higher. As summarized in Table 2, the maximum polymerization degree of GOS catalyzed by β-galactosidase from other sources does not exceed 5.
[0058] Table 2 Comparison of GOS yields catalyzed by different β-galactosidases
[0059] Source strain Enzyme catalytic form Catalytic GOS polymerization LDBUBgal Crude enzyme 2-6 Aspergillus oryzae Purification of enzymes 2-3 Kluyveromyces lactis Purification of enzymes 2-4 Bacillus circulans Purification of enzymes 2-5
[0060] Note: The polymerization degree data of GOS catalyzed by Aspergillus oryzae, Kluyveromyces lactis and Bacillus circulans are derived from public literature reports.
[0061] Comparative Example 1: Expression and hydrolysis activity of LDBUBgal by different recombinant E. coli
[0062] (1) Obtaining the LDBUBgal gene: Based on the β-galactosidase gene sequence from L. bulgaricus in the database, homologous primers for pET32a(+), pETDuet-1, and pRSFDuet-1 were designed. The primers contained homologous arms near the BamH I and EcoR I restriction sites on the multiple cloning site of pET32a(+) and plasmids to be used in the next step, and homologous arms near the Nde I and Xho I restriction sites on the MCS2 plasmids of pETDuet-1 and pRSFDuet-1. The extracted genome of L. bulgaricus was used as a template to obtain the LDBUBgal target gene by PCR, and the PCR product was recovered by agarose gel.
[0063] (2) Construction of three recombinant expression vectors of LDBUBgal: The schematic diagram of the three recombinant expression vectors pET32a(+)-LDBUBgal, pRSFDuet-1-LDBUBgal and pETDuet-1-LDBUBgal is shown in the figure. Figure 5 A. The pET32a(+) vector was double-digested with BamH I and EcoR I, and the pETDuet-1 and pRSFDuet-1 were double-digested with Nde I and Xho I, and the digested products were recovered by agarose gel. The digested products and the LDBUBgal target gene obtained by PCR amplification were connected with homologous recombinase, reacted at 37°C for 30 minutes to promote the recombination of the target gene and the vector, and the homologous recombinant products were transformed into Escherichia coli JM109. After overnight culture at 37°C, positive transformants were picked out and verified by colony PCR using the above primers. Figure 5 The nucleic acid electrophoresis diagrams corresponding to the three recombinant expression vectors in B. The transformants shown in lanes 1-6 in the three diagrams are all initially verified correct transformants. The positive transformants were transferred to 5 ml LB medium, cultured in a shaking incubator at 37°C for 12 hours, and then sent for sequencing analysis, and the plasmids therein were extracted respectively.
[0064] (3) Construction of three recombinant strains of LDBUBgal: The three recombinant plasmids pET32a(+)-LDBUBgal, pRSFDuet-1-LDBUBgal and pETDuet-1-LDBUBgal sequenced correctly in step (2) were transformed into Escherichia coli Rosetta-gami (DE3) to obtain recombinant strains Escherichia coli Rosetta-pET32a(+)-LDBUBgal, Escherichia coli Rosetta-pRSFDuet-1-LDBUBgal and Escherichia coli Rosetta-pETDuet-1-LDBUBgal.
[0065] (4) Expression of LDBUBgal by three recombinant E. coli: The three recombinant strains were induced at 25°C using a lactose induction concentration of 20 mM. Figure 6 As shown in the extracellular protein expression and intracellular protein expression of A, the LDBUBgal expressed by the three recombinant strains were all concentrated in the cells, and there were almost no detectable target protein bands outside the cells, indicating that the three recombinant strains failed to achieve secretory expression of LDBUBgal.
[0066] (5) The intracellular and extracellular hydrolysis activities of the three recombinant strains were tested. Figure 6 As shown in B, the extracellular hydrolysis activity is low, with an activity of less than 300 U / mL, and the intracellular hydrolysis activity is at 5×10 4 The level of U / mL is far from the hydrolytic activity that can be achieved in Example 1.
[0067] Comparative Example 2: Detection of the conversion activity of commercial lactase to lactose
[0068] (1) Setting up the transformation system: Use 10 mL of the transformation system, the initial concentration of lactose used is 60%, heat it to 90°C to dissolve it, and adjust the pH of the system to about 7.4 after cooling to room temperature; add three commercial lactase solutions with hydrolysis activities of 500-1000 U / mL respectively, and replace the control group with the same volume of buffer without enzyme solution. The experimental group containing enzyme solution and the control group without enzyme solution are placed at 37°C and 100-220 rpm for reaction for 3-24 hours;
[0069] (2) Product post-treatment and detection analysis: The above reaction system was heated at 100°C for 10 minutes to inactivate the enzyme in the system, and centrifuged at 12,000 rpm for 10 minutes to remove the denatured enzyme to obtain a converted sugar solution. The solution was appropriately diluted and analyzed by HPLC, and the GOS generation was calculated. According to calculation and analysis, the conversion rate of lactose can reach more than 98%, and the GOS yields catalyzed by the three commercial lactases WL1, WL2 and WL3 can reach 39%, 51% and 56% respectively, which are lower than the GOS yield generated by the conversion of lactose by LDBUBgal.
[0070] Table 3 Comparison of GOS yields catalyzed by different β-galactosidases
[0071] β-Galactosidase source Catalytic GOS yield% Catalytic GOS production (g / L) LDBUBgal Embodiments of the present invention 71 460 WL1 Commercially available products 39 234 WL2 Commercially available products 51 306 WL3 Commercially available products 56 336
[0072] Obviously, the above embodiments are merely examples for clear explanation and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. The obvious changes or modifications derived from these are still within the protection scope of the invention.
Claims
1. An Escherichia coli that efficiently secretes and expresses β-galactosidase, characterized in that: The Escherichia coli uses the pET28a vector in the starting strain to heterologously express the β-galactosidase derived from Lactobacillus delbrueckii subspecies bulgaricus.
2. The Escherichia coli according to claim 1, characterized in that: The nucleotide sequence of the β-galactosidase is shown in SEQ ID NO.
3.
3. A microbial agent comprising the Escherichia coli according to claim 1.
4. Use of the Escherichia coli according to claim 1 or the microbial agent according to claim 3 in the preparation of β-galactosidase.
5. The use according to claim 4, characterized in that: Lactose is added into the expression system to induce the Escherichia coli to express β-galactosidase extracellularly.
6. The use according to claim 5, characterized in that: The induction was performed at a temperature of 25-30°C.
7. The use according to claim 5, characterized in that: The concentration of lactose is 8-30 mM.
8. The use according to claim 5, characterized in that: The induction lasts for 16-28 hours.
9. Use of the Escherichia coli according to claim 1 or the microbial agent according to claim 3 in synthesizing galacto-oligosaccharides.
10. The use according to claim 9, characterized in that: The following steps are involved: Step S1, adding lactose to the expression system to induce the Escherichia coli to express β-galactosidase extracellularly, obtaining enzyme solution; Step S2: The conversion system uses lactose as a substrate, and the concentration of lactose in the system is 3-60%. Add enzyme solution to carry out conversion reaction.
Citation Information
Cited By
Beta-glucosidase mutant, nucleic acid molecule and application thereof
CN119931995A
A beta-glucosidase mutant, nucleic acid molecule and application thereof
CN119931995B
